Starling Oncology STLN
NASDAQ STLN
$5.95 -0.14 (-2.30%)
As of: Sep 3, 2026 · 2:44 PM EDT

Starling Oncology (STLN) Gross Profit (2021 - 2026)

Analysis

Starling Oncology (STLN) Gross Profit (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 90.68 Bn 89.67 Bn 15.19 Bn
2 Tenet Healthcare 22.03 Bn 19.86 Bn 4.45 Bn
3 Encompass Health 12.07 Bn 11.93 Bn 1.34 Bn
4 Davita 11.73 Bn 11.05 Bn 1.16 Bn
5 Universal Health Services 10.15 Bn 10.01 Bn 3.29 Bn
6 Ensign 9.95 Bn 9.63 Bn 306.24 Mn
7 Chemed 6.91 Bn 6.87 Bn 221.47 Mn
8 Pacs 6.68 Bn 6.51 Bn 338.46 Mn
9 Concentra Group Holdings Parent 4.30 Bn 4.14 Bn 192.10 Mn
10 Starling Oncology 613.04 Mn 571.94 Mn 27.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 27.17 Mn
Mar 31, 2026 23.32 Mn
Dec 31, 2025 228.50 Mn
Sep 30, 2025 18.92 Mn
Jun 30, 2025 17.50 Mn
Mar 31, 2025 17.25 Mn
Dec 31, 2024 167.17 Mn
Sep 30, 2024 14.37 Mn
Jun 30, 2024 52.06 Mn
Mar 31, 2024 45.17 Mn
Dec 31, 2023 37.42 Mn
Sep 30, 2023 37.07 Mn
Jun 30, 2023 35.35 Mn
Mar 31, 2023 33.38 Mn
Dec 31, 2022 33.04 Mn
Sep 30, 2022 28.85 Mn
Jun 30, 2022 28.05 Mn
Mar 31, 2022 27.78 Mn
Dec 31, 2021 24.95 Mn
Sep 30, 2021 26.88 Mn